GB201814141D0 - Method and compositions for producing a virus - Google Patents

Method and compositions for producing a virus

Info

Publication number
GB201814141D0
GB201814141D0 GBGB1814141.6A GB201814141A GB201814141D0 GB 201814141 D0 GB201814141 D0 GB 201814141D0 GB 201814141 A GB201814141 A GB 201814141A GB 201814141 D0 GB201814141 D0 GB 201814141D0
Authority
GB
United Kingdom
Prior art keywords
virus
compositions
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1814141.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB1814141.6A priority Critical patent/GB201814141D0/en
Publication of GB201814141D0 publication Critical patent/GB201814141D0/en
Priority to SG11202101897VA priority patent/SG11202101897VA/en
Priority to CA3109429A priority patent/CA3109429A1/en
Priority to EP19768730.4A priority patent/EP3843781A2/en
Priority to US17/269,450 priority patent/US20210310027A1/en
Priority to KR1020217008905A priority patent/KR20210052490A/ko
Priority to JP2021508285A priority patent/JP2021533791A/ja
Priority to PCT/EP2019/073181 priority patent/WO2020043869A2/en
Priority to AU2019332107A priority patent/AU2019332107A1/en
Priority to MX2021002374A priority patent/MX2021002374A/es
Priority to CN201980055820.1A priority patent/CN112638412A/zh
Priority to ZA2021/01026A priority patent/ZA202101026B/en
Priority to JP2024101633A priority patent/JP2024123193A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/463—Cellular immunotherapy characterised by recombinant expression
    • A61K39/4634—Antigenic peptides; polypeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1814141.6A 2018-08-30 2018-08-30 Method and compositions for producing a virus Ceased GB201814141D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1814141.6A GB201814141D0 (en) 2018-08-30 2018-08-30 Method and compositions for producing a virus
CN201980055820.1A CN112638412A (zh) 2018-08-30 2019-08-30 产生病毒的方法和组合物
JP2021508285A JP2021533791A (ja) 2018-08-30 2019-08-30 ウイルスを生成する方法及び組成物
CA3109429A CA3109429A1 (en) 2018-08-30 2019-08-30 Methods and compositions for producing a virus
EP19768730.4A EP3843781A2 (en) 2018-08-30 2019-08-30 Methods and compositions for producing a virus
US17/269,450 US20210310027A1 (en) 2018-08-30 2019-08-30 Methods and compositions for producing a virus
KR1020217008905A KR20210052490A (ko) 2018-08-30 2019-08-30 바이러스 생산을 위한 방법 및 조성물
SG11202101897VA SG11202101897VA (en) 2018-08-30 2019-08-30 Methods and compositions for producing a virus
PCT/EP2019/073181 WO2020043869A2 (en) 2018-08-30 2019-08-30 Methods and compositions for producing a virus
AU2019332107A AU2019332107A1 (en) 2018-08-30 2019-08-30 Methods and compositions for producing a virus
MX2021002374A MX2021002374A (es) 2018-08-30 2019-08-30 Metodos y composiciones para producir un virus.
ZA2021/01026A ZA202101026B (en) 2018-08-30 2021-02-15 Methods and compositions for producing a virus
JP2024101633A JP2024123193A (ja) 2018-08-30 2024-06-25 ウイルスを生成する方法及び組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1814141.6A GB201814141D0 (en) 2018-08-30 2018-08-30 Method and compositions for producing a virus

Publications (1)

Publication Number Publication Date
GB201814141D0 true GB201814141D0 (en) 2018-10-17

Family

ID=63921027

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1814141.6A Ceased GB201814141D0 (en) 2018-08-30 2018-08-30 Method and compositions for producing a virus

Country Status (12)

Country Link
US (1) US20210310027A1 (zh)
EP (1) EP3843781A2 (zh)
JP (2) JP2021533791A (zh)
KR (1) KR20210052490A (zh)
CN (1) CN112638412A (zh)
AU (1) AU2019332107A1 (zh)
CA (1) CA3109429A1 (zh)
GB (1) GB201814141D0 (zh)
MX (1) MX2021002374A (zh)
SG (1) SG11202101897VA (zh)
WO (1) WO2020043869A2 (zh)
ZA (1) ZA202101026B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114350621A (zh) * 2021-12-31 2022-04-15 苏州博腾生物制药有限公司 一种裂解昆虫细胞及哺乳动物细胞的裂解液和裂解方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1800375A (zh) * 2005-12-23 2006-07-12 南京农业大学 猪繁殖与呼吸综合征与猪圆环病毒重组腺病毒及疫苗
JP2010148440A (ja) * 2008-12-25 2010-07-08 Japan Health Science Foundation 組換えアデノウイルス迅速構築システム
GB201108879D0 (en) * 2011-05-25 2011-07-06 Isis Innovation Vector
GB201322851D0 (en) * 2013-12-23 2014-02-12 Psioxus Therapeutics Ltd Method
GB2549809C (en) * 2016-06-23 2022-11-30 Univ Oxford Innovation Ltd Vector

Also Published As

Publication number Publication date
CA3109429A1 (en) 2020-03-05
SG11202101897VA (en) 2021-03-30
JP2024123193A (ja) 2024-09-10
JP2021533791A (ja) 2021-12-09
EP3843781A2 (en) 2021-07-07
ZA202101026B (en) 2022-09-28
WO2020043869A3 (en) 2020-04-09
WO2020043869A2 (en) 2020-03-05
US20210310027A1 (en) 2021-10-07
MX2021002374A (es) 2021-07-15
KR20210052490A (ko) 2021-05-10
AU2019332107A1 (en) 2021-02-25
CN112638412A (zh) 2021-04-09

Similar Documents

Publication Publication Date Title
GB201907244D0 (en) Method
EP3689290C0 (de) Verfahren zur herstellung einer teil- oder totalprothese sowie prothese erhältlich nach diesem verfahren
SG11201911790TA (en) Fuel composition and method for producing a fuel composition
GB201909562D0 (en) Method
GB201911286D0 (en) Method
SG11202108435WA (en) Method for virus production
GB201910759D0 (en) Method
IL289337A (en) Methods and preparations for the preparation of hepatocytes
PT3735405T (pt) Processo para fabrico de di-isocianatos de metilenodifenileno e poli-isocianatos de polimetileno-polifenileno
PL3733651T3 (pl) Sposób wytwarzania kalkobutrolu
HUE061224T2 (hu) Eljárás formaszelvény elõállítására és formaszelvény
GB201913997D0 (en) Method
ZA202101026B (en) Methods and compositions for producing a virus
GB201900940D0 (en) Method
GB201900647D0 (en) Method
IL282108A (en) A method for preparing epiconazole
IL273168A (en) A compound for an epidural vaccine of hepatitis B and its production
SG10202000757YA (en) Confirming method
GB201917060D0 (en) Method
GB201910404D0 (en) Method
GB201901532D0 (en) Method
EP3579993C0 (de) Verfahren zur bildung eines formteils und formteil
EP4038198C0 (en) PROCESS
GB201916390D0 (en) Method
GB201916388D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)